Chemfab Alkalis Q2 FY27 Results Show ₹2.1 Cr Loss

Chemfab Alkalis Ltd reported revenue from operations of ₹75.6 crore for the quarter ended September 30, 2026, or Q2 FY27. Revenue was 1.3% lower than the corresponding quarter of the previous year. The company reported a net loss of ₹2.1 crore for the quarter. The reported loss was described as wider, although the supplied disclosure does not provide the comparable loss figure. The update puts focus on the company’s operating performance after a weaker revenue showing in the June 2026 quarter.

Q2 FY27 revenue declines year-on-year

Revenue from operations for Q2 FY27 stood at ₹75.6 crore. The 1.3% year-on-year decline indicates that sales were marginally below the level reported in Q2 FY26. No segment-wise revenue split, operating profit figure, or margin data was provided in the available information. As a result, the reasons behind the quarterly revenue movement cannot be quantified from the disclosed data. The company’s reported net loss of ₹2.1 crore remains the main earnings data point for the September quarter.

Net loss reported for September quarter

Chemfab Alkalis recorded a net loss of ₹2.1 crore in Q2 FY27. The available result summary characterises this as a widening loss but does not disclose the prior-year or preceding-quarter loss for direct comparison. Investors therefore have a reported quarterly loss figure but not a full bridge of the factors that affected profitability. The company had scheduled its board meeting for October 28, 2026, to consider unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The meeting was scheduled for 11:30 a.m.

Key reported financial figures

June quarter provides recent context

Chemfab Alkalis had reported revenue of ₹73.16 crore in the quarter ended June 2026. That revenue was 2.17% lower quarter-on-quarter than ₹74.78 crore and 20.08% lower year-on-year than ₹91.54 crore. Separate news data stated that consolidated net profit for the June 2026 quarter rose 124.71% to ₹5.73 crore, compared with ₹2.55 crore in the June 2025 quarter. The September-quarter revenue of ₹75.6 crore was therefore ₹2.44 crore higher than the June-quarter revenue figure. However, the Q2 update reported a net loss rather than a profit.

Board process and trading-window closure

The company’s October 21, 2026 board-meeting intimation said the board would consider and approve unaudited standalone and consolidated Q2 and half-year results. It also stated that the trading window for directors, designated employees, and insiders would remain closed from October 1, 2026, until October 30, 2026. Such closure is part of the company’s process around the handling of unpublished price-sensitive information before the results are considered. The supplied information does not state any additional board decision alongside the Q2 results. It also does not provide a detailed management explanation for the reported loss.

Ratings point to leverage and demand risks

India Ratings has affirmed Chemfab Alkalis’ bank loan facilities at IND BBB+ with a Negative outlook. The rating commentary cited weak OPVC pipe demand and elevated leverage as downside risks. It referred to net debt to EBITDA of 4.8 times. India Ratings also said recovery in the pipes segment was expected from the second half of FY27 as the order book improves. The commentary further referred to potential support from stronger caustic soda margins arising from efficiency projects.

Liquidity buffer remains part of rating assessment

The rating commentary cited undrawn working-capital lines of ₹12 crore to ₹13 crore as part of the company’s liquidity buffer. This figure is the crore equivalent of the ₹120 million to ₹130 million amount mentioned in the rating update. The agency’s Negative outlook means the factors behind its concerns, including OPVC pipe demand and leverage, remain relevant to its assessment. The supplied rating note did not provide a revised earnings forecast or a timetable for any change in outlook. It did, however, link a possible pipes-segment recovery to the second half of FY27.

Shareholder decisions before the quarter

At the company’s annual general meeting on September 9, 2026, shareholders approved all resolutions placed before them. These included adoption of audited financial statements and a dividend of ₹1.25 per share. Shareholders also approved the reappointment of director Suresh Krishnamurthi Rao. M/s SKC & Associates LLP was appointed as statutory auditor for five years. Other approvals included ratification of cost-auditor remuneration and authorisation of commission payments to non-executive directors of up to 11% of net profits.

What the Q2 update means for investors

The Q2 FY27 update combines a modest year-on-year revenue decline with a reported net loss of ₹2.1 crore. It follows a June quarter in which revenue had fallen 20.08% year-on-year, despite reported consolidated net profit of ₹5.73 crore. The available disclosures do not provide enough detail to identify the cost, pricing, volume, or segment factors behind the September-quarter loss. The rating update adds context by identifying OPVC pipe demand, leverage, caustic soda margins, and working-capital availability as relevant operating and financial issues. Further detail would depend on the company’s unaudited standalone and consolidated filings for the September quarter and half year ended September 30, 2026.